Serious illness conversations are a critical part of high-quality cancer care. These discussions help patients understand their prognosis, communicate their personal goals, and make informed decisions about future treatment options. Despite their importance, many cancer patients never have these conversations documented in their medical records.
A recent randomized clinical trial known as PATH-SIC, or Pathways to Advance Targeted and Helpful Serious Illness Conversations, explored whether simple communication prompts directed at patients, clinicians, or both could increase the frequency of these important discussions. The findings suggest that a combined approach involving both patients and healthcare providers may significantly improve the rate of serious illness conversations among patients with advanced cancer.
Patients with advanced cancer often face complex medical decisions. Research has shown that many individuals do not fully understand their prognosis and may receive aggressive end-of-life treatments that do not reflect their preferences.
Serious illness conversations give patients an opportunity to discuss what matters most to them. These conversations can address treatment goals, quality of life concerns, care preferences, and future planning. Previous studies have linked these discussions to lower anxiety, improved patient satisfaction, and care that better aligns with individual wishes.
However, despite recognized benefits, documented serious illness conversations remain relatively uncommon in oncology settings.
The PATH-SIC trial was conducted at two sites within a major academic cancer center between 2022 and 2024. Researchers enrolled more than 1,000 adult patients with advanced cancers who were identified as having a poor prognosis based on oncology treatment pathways. These pathways are clinical tools used by cancer specialists to guide treatment decisions and estimate expected outcomes.
Participants were randomly assigned to one of four groups:
The clinician nudges consisted of emails encouraging healthcare providers to initiate serious illness conversations. Patient nudges included mailed letters and questionnaires designed to encourage patients to discuss their goals and concerns during upcoming appointments.
The study revealed that combining patient and clinician nudges produced the strongest results.
Among patients who received both interventions, 17.3 percent had a documented serious illness conversation within 60 days, compared with 10.7 percent in the standard care group. Researchers found that the combined strategy significantly increased the likelihood of these conversations taking place.
When researchers expanded their analysis using natural language processing technology to identify conversations documented in clinical notes, the results became even more compelling. The combined intervention group achieved an overall serious illness conversation rate of 32.5 percent, compared with 22.6 percent in the control group.
These findings suggest that engaging both patients and clinicians can create a more supportive environment for meaningful discussions about care preferences and future planning.
One of the most important insights from the trial was that clinician-directed prompts appeared to drive most of the improvement.
While patient-only nudges showed little effect on conversation rates, clinician nudges consistently increased documentation of serious illness conversations. Researchers concluded that healthcare providers remain central to initiating and guiding these discussions.
The findings also suggest that patient engagement tools may work best when paired with active clinician involvement rather than as standalone interventions.
Another notable aspect of the study involved the use of natural language processing, or NLP.
Traditional tracking methods only counted conversations documented in a specific section of the electronic health record. However, researchers discovered that many serious illness discussions were recorded elsewhere in patient notes.
By applying NLP technology, the team identified an additional 134 conversations that would have otherwise been missed. This increased detection rates by more than 100 percent and highlighted the importance of using advanced technology to capture the full picture of patient-provider communication.
For healthcare organizations, this finding underscores the value of integrating AI-powered tools into clinical workflows.
Although the combined intervention improved results, researchers noted that overall conversation rates remained lower than desired.
Even among patients with a median survival of approximately 10 months, only about one-third had documented serious illness conversations within the study period. This indicates that significant barriers still exist.
Researchers suggested several possible reasons, including time constraints, discomfort discussing prognosis, workflow challenges, and varying patient readiness for these conversations.
Future strategies may need to include more personalized support, enhanced communication training, and additional technology tools that help clinicians identify opportunities for discussion.
The PATH-SIC trial offers valuable lessons for healthcare providers, hospitals, and policymakers seeking to improve patient-centered cancer care.
The study demonstrates that relatively simple interventions can encourage more meaningful communication between patients and clinicians. By combining clinician reminders with patient engagement efforts, healthcare organizations may be able to improve care planning and ensure that treatment decisions align more closely with individual values.
The research also highlights the growing importance of data-driven tools such as treatment pathways and natural language processing. These technologies can help identify patients who may benefit most from serious illness conversations while improving documentation and care coordination.
As cancer care continues to evolve, communication will remain a cornerstone of quality treatment. Serious illness conversations help patients understand their options, express their priorities, and participate actively in decisions about their care.
The PATH-SIC study provides encouraging evidence that targeted interventions can increase the frequency of these important discussions. While more work is needed to achieve higher engagement rates, the findings point toward practical and scalable solutions that could benefit patients facing some of the most challenging moments of their healthcare journey.
Healthcare systems that invest in clinician support, patient education, and advanced documentation tools may be better positioned to deliver care that truly reflects what matters most to patients.
Manz CR, Cotner CE, Tramontano AC, et al. Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC): A Randomized Clinical Trial. Journal of the National Comprehensive Cancer Network, Volume 24, Issue 6, June 2026. DOI: 10.6004/jnccn.2025.7479. Information summarized and rephrased from the uploaded article.
This blog is intended for informational and educational purposes only. It is a rephrased summary of a published clinical research study and should not be considered medical advice, diagnosis, or treatment guidance. Patients should consult qualified healthcare professionals regarding their individual medical conditions and treatment decisions
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.